NURO

NeuroMetrix (NURO)

NeuroMetrix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NURO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/31	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NURO	NeuroMetrix Inc
2024/12/20	00 : 24	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:NURO	NeuroMetrix Inc
2024/12/18	23 : 03	PR Newswire (US)	Kuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to Contact Law Firm	NASDAQ:NURO	NeuroMetrix Inc
2024/12/18	07 : 27	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NURO	NeuroMetrix Inc
2024/12/18	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NURO	NeuroMetrix Inc
2024/12/18	06 : 05	GlobeNewswire Inc.	NeuroMetrix to be Acquired by electroCore	NASDAQ:NURO	NeuroMetrix Inc
2024/11/06	06 : 23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NURO	NeuroMetrix Inc
2024/11/06	00 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/11/05	21 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NURO	NeuroMetrix Inc
2024/11/05	21 : 00	GlobeNewswire Inc.	NeuroMetrix Reports Q3 2024 Business Highlights	NASDAQ:NURO	NeuroMetrix Inc
2024/10/03	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/09/28	04 : 56	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:NURO	NeuroMetrix Inc
2024/09/27	06 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/09/27	05 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/08/14	03 : 47	GlobeNewswire Inc.	NeuroMetrix Reiterates its Review of Strategic Alternatives	NASDAQ:NURO	NeuroMetrix Inc
2024/08/07	05 : 24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NURO	NeuroMetrix Inc
2024/08/06	20 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NURO	NeuroMetrix Inc
2024/08/06	20 : 00	GlobeNewswire Inc.	NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options	NASDAQ:NURO	NeuroMetrix Inc
2024/08/01	03 : 03	GlobeNewswire Inc.	NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call	NASDAQ:NURO	NeuroMetrix Inc
2024/06/01	02 : 15	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:NURO	NeuroMetrix Inc
2024/05/25	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/05/25	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/05/25	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/05/16	05 : 00	GlobeNewswire Inc.	NeuroMetrix Reports Q1 2024 Business Highlights	NASDAQ:NURO	NeuroMetrix Inc
2024/05/16	01 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NURO	NeuroMetrix Inc
2024/05/16	00 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NURO	NeuroMetrix Inc
2024/05/08	05 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/04/19	21 : 00	GlobeNewswire Inc.	NeuroMetrix Announces Steps Taken to Enhance Shareholder Value	NASDAQ:NURO	NeuroMetrix Inc
2024/03/14	22 : 00	GlobeNewswire Inc.	NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	NASDAQ:NURO	NeuroMetrix Inc
2024/03/13	22 : 00	GlobeNewswire Inc.	NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia	NASDAQ:NURO	NeuroMetrix Inc